Oxford Asset Management LLP Makes New Investment in Maximus, Inc. (NYSE:MMS)

Oxford Asset Management LLP acquired a new stake in Maximus, Inc. (NYSE:MMS) in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor acquired 13,097 shares of the health services provider’s stock, valued at approximately $978,000.

Several other hedge funds have also made changes to their positions in MMS. Norges Bank bought a new stake in Maximus in the fourth quarter valued at $71,443,000. Federated Hermes Inc. lifted its stake in Maximus by 74.8% in the fourth quarter. Federated Hermes Inc. now owns 882,953 shares of the health services provider’s stock valued at $65,912,000 after buying an additional 377,705 shares in the last quarter. Marshall Wace LLP raised its position in Maximus by 1,319.1% in the 4th quarter. Marshall Wace LLP now owns 224,267 shares of the health services provider’s stock valued at $16,742,000 after buying an additional 208,463 shares during the last quarter. Vanguard Group Inc. increased its stake in Maximus by 3.2% in the 4th quarter. Vanguard Group Inc. now owns 6,548,284 shares of the health services provider’s stock valued at $488,829,000 after buying an additional 205,564 shares during the last quarter. Finally, Dimensional Fund Advisors LP increased its holdings in Maximus by 14.4% during the fourth quarter. Dimensional Fund Advisors LP now owns 1,406,592 shares of the health services provider’s stock worth $105,001,000 after buying an additional 177,075 shares during the last quarter. Institutional investors own 97.21% of the company’s stock.

Insider Activity

In related news, insider Ilene R. Baylinson sold 14,500 shares of Maximus stock in a transaction on Wednesday, February 19th. The stock was sold at an average price of $68.14, for a total value of $988,030.00. Following the completion of the sale, the insider now owns 2,512 shares of the company’s stock, valued at $171,167.68. The trade was a 85.23 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, Director Jan Madsen sold 2,439 shares of the business’s stock in a transaction dated Tuesday, March 18th. The shares were sold at an average price of $67.71, for a total value of $165,144.69. Following the sale, the director now directly owns 18,097 shares of the company’s stock, valued at $1,225,347.87. This represents a 11.88 % decrease in their position. The disclosure for this sale can be found here. 1.60% of the stock is currently owned by company insiders.

Maximus Stock Down 1.6 %

MMS opened at $67.72 on Friday. The company’s 50-day moving average is $67.65 and its 200 day moving average is $74.61. The firm has a market capitalization of $3.83 billion, a P/E ratio of 14.56 and a beta of 0.68. Maximus, Inc. has a fifty-two week low of $63.77 and a fifty-two week high of $93.97. The company has a debt-to-equity ratio of 0.82, a current ratio of 1.72 and a quick ratio of 1.72.

Maximus (NYSE:MMS) last issued its quarterly earnings data on Thursday, February 6th. The health services provider reported $1.61 EPS for the quarter, beating the consensus estimate of $1.39 by $0.22. Maximus had a net margin of 5.28% and a return on equity of 21.95%. Research analysts expect that Maximus, Inc. will post 6.15 earnings per share for the current fiscal year.

Maximus Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Saturday, May 31st. Investors of record on Thursday, May 15th will be given a dividend of $0.30 per share. This represents a $1.20 annualized dividend and a dividend yield of 1.77%. The ex-dividend date is Thursday, May 15th. Maximus’s dividend payout ratio is currently 25.81%.

Analyst Upgrades and Downgrades

A number of equities analysts have commented on MMS shares. Raymond James raised shares of Maximus from a “market perform” rating to an “outperform” rating and set a $90.00 price objective for the company in a research report on Thursday, January 2nd. StockNews.com downgraded Maximus from a “buy” rating to a “hold” rating in a research note on Friday, February 14th.

Maximus Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.